NCT06724718 Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
| NCT ID | NCT06724718 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | Postoperative Atrial Fibrillation |
| Study Type | INTERVENTIONAL |
| Enrollment | 302 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 302 participants in total. It began in 2025-06-01 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.
Eligibility Criteria
Inclusion Criteria: * Adults (\>18 years old). * Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours. * Scheduled pneumonectomy or lobectomy. * Admission to a conventional surgical unit postoperatively. * Ability to perform single-lead ECG using a smartwatch. * Coverage under a social security system. * Signed informed consent Exclusion Criteria: * History of atrial fibrillation. * Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm). * Dependency on a pacemaker. * Participation in another interventional clinical trial affecting POAF incidence. * Mediastinal, pleural, or chest wall surgery. * Reoperations or surgeries performed more than 48 hours prior. * Pregnant women. * Patients under guardians or similar legal protection.
Contact & Investigator
Pierre Huette, MD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Amiens
Frequently Asked Questions
Who can join the NCT06724718 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Postoperative Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06724718 currently recruiting?
Yes, NCT06724718 is actively recruiting participants. Contact the research team at Huette.pierre@chu-amiens.fr for enrollment information.
Where is the NCT06724718 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT06724718 clinical trial?
NCT06724718 is sponsored by Centre Hospitalier Universitaire, Amiens. The principal investigator is Pierre Huette, MD at Centre Hospitalier Amiens. The trial plans to enroll 302 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.